Sponsor pipeline

Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology clinical trial pipeline

Get alerts when Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable

    MSTH-CAR002 · This is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy · Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma

    Enrolling by invitation only

    Also in this update: Study completion pushed from Dec 2031 to Dec 2032

    Minsk Scientific-Practical Center for Surgery, Transplantation and HematologyPhase 1/2 NCT07162571 Registry history of NCT07162571 on ClinicalTrials.gov (opens the registry)

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2
2

Disease areas by active trials

Get alerts when Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free